Marie Garinot
Marcy, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Author Correction: SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate.
Journal: NPJ vaccines
Published: February 06, 2025
Nonclinical safety assessment of an mRNA Covid-19 vaccine candidate following repeated administrations and biodistribution.
Journal: Journal of applied toxicology : JAT
Published: July 04, 2023
The impact of nucleoside base modification in mRNA vaccine is influenced by the chemistry of its lipid nanoparticle delivery system.
Journal: Molecular therapy. Nucleic acids
Published: December 11, 2022
Nonclinical safety assessments of a novel synthetic toll-like receptor 4 agonist and saponin based adjuvant.
Journal: Toxicology and applied pharmacology
Published: November 03, 2022
Taylor Dispersion Analysis to support lipid-nanoparticle formulations for mRNA vaccines.
Journal: Gene therapy
Published: February 11, 2022
A potent novel vaccine adjuvant based on straight polyacrylate.
Journal: International journal of pharmaceutics: X
Published: May 21, 2020
Comparison of adjuvants to optimize influenza neutralizing antibody responses.
Journal: Vaccine
Published: April 01, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026